These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25456002)

  • 21. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura.
    Pierrot-Deseilligny Despujol C; Michel M; Khellaf M; Gouault M; Intrator L; Bierling P; Godeau B
    Br J Haematol; 2008 Aug; 142(4):638-43. PubMed ID: 18510681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels.
    Stojanovich L; Kontic M; Djokovic A; Ilijevski N; Stanisavljevic N; Marisavljevic D
    Scand J Rheumatol; 2012 May; 41(3):223-6. PubMed ID: 22324785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis.
    Opatrny L; David M; Kahn SR; Shrier I; Rey E
    J Rheumatol; 2006 Nov; 33(11):2214-21. PubMed ID: 17014001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays.
    Raby A; Moffat K; Crowther M
    Methods Mol Biol; 2013; 992():387-405. PubMed ID: 23546732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The paradox of the lupus anticoagulant: history and perspectives.
    Pengo V; Bison E; Denas G; Jose SP; Bracco A; Banzato A
    Semin Thromb Hemost; 2014 Nov; 40(8):860-5. PubMed ID: 25389103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis.
    Deeb A; Hamdoun S; Dababo K
    Iran J Immunol; 2009 Sep; 6(3):154-9. PubMed ID: 19801789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
    Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC
    Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiphospholipid antibodies as risk factor for venous thromboembolism].
    Windyga J
    Pol Arch Med Wewn; 2002 Nov; 108(5):1065-70. PubMed ID: 12685247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta2-glycoprotein I dependent anticardiolipin antibodies and lupus anticoagulant in patients with recurrent pregnancy loss.
    Kumar KS; Jyothy A; Prakash MS; Rani HS; Reddy PP
    J Postgrad Med; 2002; 48(1):5-10. PubMed ID: 12082318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies.
    Tortosa C; Cabrera-Marante O; Serrano M; Martínez-Flores JA; Pérez D; Lora D; Morillas L; Paz-Artal E; Morales JM; Pleguezuelo D; Serrano A
    PLoS One; 2017; 12(7):e0178889. PubMed ID: 28727732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
    Urbanus RT; Siegerink B; Roest M; Rosendaal FR; de Groot PG; Algra A
    Lancet Neurol; 2009 Nov; 8(11):998-1005. PubMed ID: 19783216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and β-2-glycoprotein I.
    Kim H; Kim JE; Hwang SM; Lee HR; Han KS; Kim HK
    Clin Appl Thromb Hemost; 2014 May; 20(4):442-7. PubMed ID: 23892687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.